Chief among the factors driving a sense of optimism among the biopharma leaders was the unfreezing of the biotech investing ...

In 2023, Teva made a pledge to bolster its innovative medicines portfolio without leaving behind its century-long legacy as a ...

Mereo BioPharma recently reported mixed Phase 3 results for setrusumab in osteogenesis imperfecta, updated its cash runway to ...

Biopharma is reshaping the healthcare industry, and smart investors are paying close attention. The healthcare sector could see major changes as artificial intelligence accelerates drug discovery, ...

If you are wondering whether Xeris Biopharma Holdings is attractively priced or getting ahead of itself, the recent share ...

Symbolic milestone for new buffer media station: Rentschler Biopharma underscores its commitment to the Laupheim headquarters and to the future of Germany and Europe as leading biotechnology hubs ...